Scale Up Lab Data Management with Scispot's Advanced Lab Inventory Automation Features

At Scispot, we are dedicated to making microbial research workflows more efficient and streamlined. Join us today and experience the power of Scispot in your lab. Say goodbye to the complexities of managing and organizing multiple tasks – our LIMS software, electronic lab notebook, and sample tracking capabilities have got you covered! Contact us now to learn how our laboratory information management systems can help you achieve your research goals faster and more efficiently. https://www.scispot.com/

TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion

GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024

For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions

For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions

Debiopharm Partners with Genedata to Digitalize Translational Research

Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy

Sustainable medicines packaging awards shortlist announced

Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma

AI-Designed Cancer Drug from Insilico Medicine Receives FDA IND Approval to Advance to Clinical Trials

Insilico Medicine, a leading company in the use of generative artificial intelligence (AI) for drug discovery and design, has announced that it has received investigational new drug (IND) approval from the FDA for its novel, small molecule inhibitor of USP1 to treat solid tumors. It's the first of Insilico's numerous AI-designed cancer drugs to advance to the clinical validation stage.

Endor Labs Receives Intellyx Digital Innovation Award

Endor Labs, a startup securing open source software (OSS) and the supply chain, has received the Intellyx Digital Innovation Award, which recognizes technology providers who make it through the analyst firm’s rigorous briefing selection process – leading-edge vendors driving enterprise digital transformation.

Expert.ai Launches AI Platform for Life Sciences

Expert.ai Platform for Life Sciences strengthens solutions and industry practice honed by expert.ai from real-world implementations with global organizations and scientific publishers such as Sanofi, New England Journal of Medicine, EBSCO, 3M Health, and INSERM. Our new Platform for Life Sciences has been chosen as a “Best of Show” finalist for 2023 Bio-IT Awards!

Rhapsody Names New Chief Financial Officer

New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database

Summary of Large-Scale RNA Synthesis Methods

Speeding Up The Cancer Drug Discovery Process with Zebrafish Disease Models

Form Bio Selected by Google Cloud to Help Organizations Adopt New AI-powered Life Sciences Solutions

Form Bio, the breakthrough computational life sciences platform, announced today that it has been selected to help organizations adopt Google Cloud’s Multiomics Suite, accelerating the research of life science companies and academic institutions. In addition, Form Bio has been designated by Google as a Google Cloud Premier partner.

Inizio Targets Innovation and AI-Led Growth with Two Top Appointments

Global strategic advisory agency Inizio has announced two senior leadership appointments to its Inizio Medical division, strengthening the AI and innovation capabilities of the business.

Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry

OMICSEDGE FORMS STRATEGIC PARTNERSHIP WITH ALMADEN GENOMICS TO STREAMLINE DRUG DISCOVERY

OmicsEdge has launched an industry leading drug discovery service that leverages Almaden’s g.nome™ platform to streamline the iteration process. The service makes it easy for labs to conduct a quick analysis of a patient or trial participant’s medical condition and genomics, gaining valuable insight in genomic criteria and how it affects elevated risk. It can be used to significantly accelerate the drug discovery process and eliminate trial-and-error with abilities such as identifying causal variants that make ideal drug targets.

CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs

CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service

CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis

The Next Era of AI Drug Discovery? Quantum Computing

A consortium of international scientists has taken the first step toward incorporating quantum computing into AI-powered drug discovery.